Orthopedic oncology: What’s new in 2019?

Simon, P.

doi:10.1007/s00590-019-02562-9

Cited by 3 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been many publications recently from single centre and multicenter study showing increased mortality rates in NOF patient with COVID-19 positive infection 7 , 8 , 9 , 10 , 11 , 12 , 13 reporting between 30 and 35% mortality compared to 7 and 10% in non-COVID positive patients. The largest from Dupley et al 9 involving 64 COVID-19 positive patients showed 32.8% 30-day mortality.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Thirty-day mortality and reliability of Nottingham Hip Fracture Score in patients with COVID19 infection

Fell

Malik-Tabassum

Rickman

et al. 2021

Journal of Orthopaedics

View full text Add to dashboard Cite

In March 2020 Coronavisus-19 pandemic led to significant changes in operations in healthcare in the United Kingdom with national lockdown measures imposed to help protect the vulnerable and prevent transmission. Those deemed vulnerable fall into the cohort of patients at risk of fragility fractures such as fracture neck of femur (NOF). British Orthopaedic Association released guidelines advising that NOF fractures should continue to be treated urgently. Aim Our unit aimed to identify changes in NOF caseload during the national lockdown and identify if Nottingham Hip Fracture Scores (NHFS) were reliable at predicting 30-day mortality in COVID-19 positive patients. Methods A retrospective observational study identifying NOF admissions over a 6-week period in 2020 during lockdown period, where demographics, NHFS, and 30-day mortality rates were compared against the same period in 2019. Results There was a reduction in NOF admissions by 17.8% (55 vs 67). No significant difference in patient demographics between groups. 30-day mortality rates were not significantly increased in 2020 compared with 2019. COVID-19 positive patients had significantly increased 30-day mortality rates (54%, p = 0.001) compared to COVID-19 negative (9.1%, p = 0.395) and 2019 (6%). Discussion NHFS was not reliable as a predictor for 30-day mortality in COVID-19 positive patients. Our unit reports increased mortality rates in NOF patients with covid-19 infection. This adds to the building evidence that COVID-19 is an independent predictor for mortality in NOF patients irrespective of NHFS. This should be communicated to patients who are admitted to hospital with NOF and units should continue with efforts to prevent hospital acquired COVID-19 infection.

show abstract

Section: Discussionmentioning

confidence: 99%

“…15 Our institution did not see a change in patients who were more high risk for surgery, which mirrors that of the current literature. 7 , 8 , 9 , 10 , 11 , 12 , 13 …”

Section: Discussionmentioning

confidence: 99%

Thirty-day mortality and reliability of Nottingham Hip Fracture Score in patients with COVID19 infection

Fell

Malik-Tabassum

Rickman

et al. 2021

Journal of Orthopaedics

View full text Add to dashboard Cite

show abstract

“…5,14 One of the key strategies here is to reduce the number of surgeries and elective operations in the entire hospital. 15 At first glance, the COVID-19 pandemic and orthopedics may seem to be unrelated disciplines, but the provision of healthcare services to patients who require them proves that these two fields are parts of the same whole. Our orthopedics and traumatology clinic was This success is the result of the multidisciplinary cooperation of the Ministry of Health, our hospital, and our clinic.…”

Section: Discussionmentioning

confidence: 99%

Management of orthopedic oncology patients during coronavirus pandemic

Şahbat

Buyuktopcu

Topkar

et al. 2020

Journal of Surgical Oncology

View full text Add to dashboard Cite

The new measures implemented in hospitals also altered the operation of orthopedics and traumatology departments. The main purpose of this article is to discuss how orthopedic oncology clinics should be organized during the pandemic and to present the process management scheme for patients requiring orthopedic surgery, including trauma surgery, from diagnosis to treatment, together with our experiences. Instead of thinking about the global emergence of the epidemic, it is time to act decisively. At first glance, the coronavirus disease 2019 (COVID‐19) pandemic and orthopedics may seem to be unrelated disciplines, but the provision of healthcare services to patients who require them proves that these two fields are parts of the same whole. Our experiences in treating neutropenic, lymphocytopenic, and chemotherapy patients seem to have proven beneficial during this process. We operated on 10 biopsy patients, 15 primary bone sarcomas, 9 soft tissue sarcomas, and 82 trauma patients within this time frame. Only three patients were suspected to have COVID‐19 before admission. The early identification, strict isolation, and effective treatment of these patients prevented any nosocomial infections and disease‐related comorbidities. This success is the result of the multidisciplinary cooperation of the Ministry of Health, our hospital, and our clinic.

show abstract

The role of patient advocates and sarcoma community initiatives in musculoskeletal oncology. Moving towards Evidence-Based Advocacy to empower Evidence-Based Medicine

Gonzato¹,

Schuster²

2023

Journal of Cancer Policy

View full text Add to dashboard Cite

Orthopedic oncology: What’s new in 2019?

Cited by 3 publications

References 9 publications

Thirty-day mortality and reliability of Nottingham Hip Fracture Score in patients with COVID19 infection

Thirty-day mortality and reliability of Nottingham Hip Fracture Score in patients with COVID19 infection

Management of orthopedic oncology patients during coronavirus pandemic

The role of patient advocates and sarcoma community initiatives in musculoskeletal oncology. Moving towards Evidence-Based Advocacy to empower Evidence-Based Medicine

Contact Info

Product

Resources

About